AAAAAA

   
Results: 1-6 |
Results: 6
Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition
Authors: Chaturvedi, N Fuller, JH Pokras, F Rottiers, R Papazoglou, N Aiello, LP
Citation: N. Chaturvedi et al., Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition, DIABET MED, 18(4), 2001, pp. 288-294
Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index
Authors: Weets, I Van Autreve, J Van der Anwera, BJ Schuit, FC Du Caju, MVL Decochez, K De Leeuw, IH Keymeulen, B Mathieu, C Rottiers, R Dorchy, H Quartier, E Gorus, FK
Citation: I. Weets et al., Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index, DIABETOLOG, 44(1), 2001, pp. 40-47
Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids
Authors: Buyken, AE Toeller, M Heitkamp, G Karamanos, B Rottiers, R Muggeo, M Fuller, JH
Citation: Ae. Buyken et al., Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids, AM J CLIN N, 73(3), 2001, pp. 574-581
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset
Authors: Decochez, K Keymeulen, B Somers, G Dorchy, H De Leeuw, IH Mathieu, C Rottiers, R Winnock, F ver Elst, K Weets, I Kaufman, L Pipeleers, DG Gorus, FK
Citation: K. Decochez et al., Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset, DIABET CARE, 23(8), 2000, pp. 1072-1078
Different risk factors of microangiopathy in patients with Type I diabetesmellitus of short versus long duration. The EURODIAB IDDM Complications Study
Authors: Karamanos, B Porta, M Songini, M Metelko, Z Kerenyi, Z Tamas, G Rottiers, R Stevens, LK Fuller, JH
Citation: B. Karamanos et al., Different risk factors of microangiopathy in patients with Type I diabetesmellitus of short versus long duration. The EURODIAB IDDM Complications Study, DIABETOLOG, 43(3), 2000, pp. 348-355
Insulin lispro (Humalog((R))) in the treatment of diabetes mellitus: Overview of Belgian clinical data from global studies
Authors: Bex, M Buysschaert, M De Leeuw, I De Schepper, J Fery, F Hermans, MP Keymeulen, B Lauvaux, JP Letiexhe, M Mathieu, C Nobels, FR Rottiers, R Scheen, A Schmitt, H Van Crombrugge, P Van Gaal, L
Citation: M. Bex et al., Insulin lispro (Humalog((R))) in the treatment of diabetes mellitus: Overview of Belgian clinical data from global studies, ACT CLIN B, 54(5), 1999, pp. 241-245
Risultati: 1-6 |